A "Pre-Enrollment" Protocol for HIV-Infected Adolescents
Launched by NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) · Aug 30, 2001
Trial Information
Current as of May 14, 2025
Completed
Keywords
ClinConnect Summary
Little is known about HIV-infected adolescents as a group and, as a result, small numbers of them are currently enrolled in ACTG drug studies. Creative approaches are needed to encourage enrollment of HIV-infected adolescents whose socio-demographic profile has made access to NIH-sponsored research unlikely.
At entry and at every subsequent visit, participants are systematically evaluated for eligibility and willingness to enter ACTG (or other NIH-sponsored) HIV treatment protocols from a menu developed and updated by the Pediatric Adolescent Working Group of the ACTG. A survey of particip...
Gender
ALL
Eligibility criteria
- • Inclusion Criteria
- Participants must meet the following criteria:
- • HIV infection.
- • NOT currently enrolled in an ACTG treatment protocol.
- • Exclusion Criteria
- Co-existing Condition:
- Participants with the following condition are excluded:
- • No legal provision for consent to participate in clinical research can be determined.
About National Institute Of Allergy And Infectious Diseases (Niaid)
The National Institute of Allergy and Infectious Diseases (NIAID) is a key component of the National Institutes of Health (NIH) dedicated to advancing the understanding, prevention, and treatment of infectious and immune-mediated diseases. Through rigorous clinical trials, NIAID aims to foster innovative research that enhances public health and addresses global health challenges, including emerging infectious diseases and allergies. The institute collaborates with various partners, including academic institutions, industry, and international organizations, to translate scientific discoveries into effective therapies and vaccines. NIAID's commitment to high-quality clinical research is integral to improving health outcomes and informing policy decisions in the realm of infectious diseases and immunology.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Worcester, Massachusetts, United States
New York, New York, United States
Bronx, New York, United States
Birmingham, Alabama, United States
Long Beach, California, United States
Los Angeles, California, United States
Oakland, California, United States
San Francisco, California, United States
Denver, Colorado, United States
Washington, District Of Columbia, United States
Washington, District Of Columbia, United States
Miami, Florida, United States
Atlanta, Georgia, United States
Chicago, Illinois, United States
Chicago, Illinois, United States
Baltimore, Maryland, United States
Boston, Massachusetts, United States
Boston, Massachusetts, United States
Brooklyn, New York, United States
Buffalo, New York, United States
New Hyde Park, New York, United States
New York, New York, United States
New York, New York, United States
New York, New York, United States
Valhalla, New York, United States
Durham, North Carolina, United States
Cincinnati, Ohio, United States
Columbus, Ohio, United States
Philadelphia, Pennsylvania, United States
Philadelphia, Pennsylvania, United States
Charleston, South Carolina, United States
Memphis, Tennessee, United States
Bayamon, , Puerto Rico
San Juan, , Puerto Rico
San Juan, , Puerto Rico
Los Angeles, California, United States
Omaha, Nebraska, United States
Bronx, New York, United States
Buffalo, New York, United States
Cincinnati, Ohio, United States
Los Angeles, California, United States
Hershey, Pennsylvania, United States
Knoxville, Tennessee, United States
New Orleans, Louisiana, United States
Jacksonville, Florida, United States
Washington, District Of Columbia, United States
New Orleans, Louisiana, United States
Dayton, Ohio, United States
Houston, Texas, United States
Wauwatosa, Wisconsin, United States
Patients applied
Trial Officials
D'Angelo LJ
Study Chair
Futterman D
Study Chair
Abdalian S
Study Chair
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials